Sarepta Therapeutics, Inc. (NASDAQ:SRPT) initiated the shares trading at $61.55 and showed negative change of -6.24% while the stock’s final trade was registered at $ 57.89. However, its previous closing price was seen at $61.74. The stock negotiated total number of 8.99 million shares as compared to 3 months average volume of 4.1 million shares.
The stock price demonstrated downbeat change from its 50 day moving average of 40.98 and had been up from its 200 Day Moving Average of 25.39.
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago, shares have been suggested as “BUY” from “5” brokerage firms and recommended as “Strong Buy” by “1” brokerage firms. 3” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “3” brokerage firms. “1” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 2.67 based on consensus of the brokerage firms issuing ratings.
The average true range of Sarepta Therapeutics, Inc.’s (SRPT) is recorded at 3.53 and the relative strength index of the stock stands 66.33. The stock price is going above to its 52 week low with 623.62% and lagging behind from its 52 week high with -9.16%. Analyst recommendation for this stock stands at 1.80. A look on the firm performance, its monthly performance is 102.06% and a quarterly performance of 170.89%. The stock price is trading upbeat from its 200 days moving average with 146.49% and up from 50 days moving average with 62.00%.
Shares of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) declined -0.706% and ended at $0.422 smaller than previous closing price of $0.425. The total 934.89 thousand shares were bought and sold throughout the most recent trading session less than average volume of 2.15 million shares.
Northwest Biotherapeutics, Inc.’s (NWBO) has price-to-cash ratio of 23.00 and price to sale ratio of 32.20. A look on the firm performance, its monthly performance is 22.75% and a quarterly performance of -16.77%. The stock price is moving down from its 20 days moving average with -19.01% and isolated negatively from 50 days moving average with -4.63%.